Division of STD Prevention, CDC Foundation, Centers for Disease Control and Prevention, and Emory University, Atlanta, Georgia.
Obstet Gynecol. 2024 Oct 1;144(4):493-500. doi: 10.1097/AOG.0000000000005700. Epub 2024 Aug 15.
To identify trends in stillbirth rates attributed to congenital syphilis in the United States by describing congenital syphilis-related stillbirths and comparing characteristics of pregnant people who had congenital syphilis-related stillbirths with those of people who had preterm and full-term liveborn neonates with congenital syphilis.
Cases of congenital syphilis reported to the Centers for Disease Control and Prevention during 2016-2022 were analyzed and categorized as stillbirth, preterm live birth (before 37 weeks of gestation), or term live birth (37 weeks or later). Cases with unknown vital status or gestational age were excluded. Frequencies were calculated by pregnancy outcome, including pregnant person demographics; receipt of prenatal care; syphilis stage and titer; and timing of prenatal care, testing, and treatment.
Overall, 13,393 congenital syphilis cases with vital status and gestational age were reported; of these, 853 (6.4%) were stillbirths. The number of congenital syphilis-related stillbirths increased each year (from 44 to 231); the proportion of congenital syphilis cases resulting in stillbirth ranged from 5.2% to 7.5%. Median gestational age at delivery for stillborn fetuses was 30 weeks (interquartile range 26-33 weeks). People with congenital syphilis-related stillbirths were more likely to have titers at or above 1:32 (78.9% vs 45.5%; P <.001) and to have received no prenatal care (58.4% vs 33.1%; P <.001) than people with liveborn neonates with congenital syphilis. The risk of stillbirth was twice as high in persons with secondary syphilis compared with those with primary syphilis (11.5% vs 5.7%, risk ratio 2.00; 95% CI, 1.27-3.13). Across all congenital syphilis cases, 34.2% of people did not have a syphilis test at their first prenatal visit.
Stillbirths occurred in more than 1 in 20 pregnancies complicated by congenital syphilis. Risk factors for stillbirth included high titers, secondary stage, and lack of prenatal care. If the prevalence of congenital syphilis continues to rise, there will be a corresponding increase in the overall stillbirth rate nationally.
通过描述先天性梅毒相关死产病例,并比较先天性梅毒相关死产孕妇与患有先天性梅毒的早产儿和足月活产新生儿的特征,来确定美国先天性梅毒导致的死产率趋势。
对 2016 年至 2022 年向疾病控制与预防中心报告的先天性梅毒病例进行分析,并按妊娠结局分为死产、早产(妊娠 37 周前)和足月产(妊娠 37 周或以上)。排除未知存活状态或胎龄的病例。根据妊娠结局(包括孕妇人口统计学特征、接受产前护理情况、梅毒分期和滴度、产前护理、检测和治疗的时间)计算频率。
共有 13393 例先天性梅毒病例报告了存活状态和胎龄,其中 853 例(6.4%)为死产。先天性梅毒相关死产的数量逐年增加(从 44 例增加到 231 例);先天性梅毒导致死产的比例从 5.2%到 7.5%不等。死胎的中位分娩孕周为 30 周(四分位距 26-33 周)。先天性梅毒相关死产孕妇的滴度在 1:32 及以上的可能性更大(78.9%比 45.5%;P <.001),且未接受产前护理的可能性更大(58.4%比 33.1%;P <.001),而先天性梅毒活产新生儿的上述可能性更小。与一期梅毒相比,二期梅毒患者死产的风险高两倍(11.5%比 5.7%,风险比 2.00;95%CI,1.27-3.13)。在所有先天性梅毒病例中,有 34.2%的孕妇首次产前就诊时未进行梅毒检测。
在先天性梅毒引起的妊娠中,每 20 例妊娠中就有超过 1 例发生死产。死产的危险因素包括高滴度、二期梅毒和缺乏产前护理。如果先天性梅毒的流行率继续上升,全国的总死产率将会相应增加。